PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Complement Decay-Accelerating Factor 19 Target Disease Rheumatoid Arthritis 78,952 2 0.00 -0.95 0.11 0.59
Doxacurium Chloride 19 Drug Disease Hypotension 42,123 1 0.00 -0.97 0.05 0.59
464.1 19 Target Disease Hypotension 42,123 1 0.00 -0.97 0.05 0.59
Complement Decay-Accelerating Factor 19 Target Disease Arthritis 128,324 3 0.00 -0.92 0.16 0.59
Aralen (Chloroquine)- FDA 19 Drug Disease Arthritis 128,324 3 0.00 -0.92 0.16 0.59
ALK Phos 19 Target Disease Liver Disease 49,817 1 0.00 -0.97 0.05 0.59
AMAC-1 19 Target Disease Inflammation 252,734 5 0.00 -0.86 0.26 0.59
Eotaxin-2/CCL24 19 Target Disease Inflammation 252,734 5 0.00 -0.86 0.26 0.59
ALK Phos 19 Target Disease Cholesterol 182,390 3 0.00 -0.92 0.16 0.58
Kaad-Cyclopamine 19 Drug Disease Carcinoma 433,099 7 0.00 -0.79 0.37 0.58
Aralen (Chloroquine)- FDA 19 Drug Disease Shock 134,031 2 0.00 -0.95 0.11 0.58
Kaad-Cyclopamine 19 Drug Disease Prostate Cancer 71,064 1 0.00 -0.97 0.05 0.58
Doxacurium Chloride 19 Drug Disease Depression 220,092 3 0.00 -0.92 0.16 0.58
Doxacurium Chloride 19 Drug Disease Stroke 146,992 2 0.00 -0.95 0.11 0.58
AMAC-1 19 Target Disease Rheumatoid Arthritis 78,952 1 0.00 -0.97 0.05 0.58
Aralen (Chloroquine)- FDA 19 Drug Disease Rheumatoid Arthritis 78,952 1 0.00 -0.97 0.05 0.58
Eotaxin-2/CCL24 19 Target Disease Rheumatoid Arthritis 78,952 1 0.00 -0.97 0.05 0.58
Kaad-Cyclopamine 19 Drug Disease Cancer 1,053,491 13 0.00 -0.56 0.68 0.58
Amitiza (Lubiprostone)- FDA 19 Drug Disease Pain 409,851 5 0.00 -0.86 0.26 0.58
Kaad-Cyclopamine 19 Drug Disease Breast Cancer 173,695 2 0.00 -0.95 0.11 0.58
Kallikrein-8 19 Target Disease Breast Cancer 173,695 2 0.00 -0.95 0.11 0.58
Kaad-Cyclopamine 19 Drug Disease Lung Cancer 91,416 1 0.00 -0.97 0.05 0.58
Kallikrein-8 19 Target Disease Lung Cancer 91,416 1 0.00 -0.97 0.05 0.58
464.1 19 Target Disease Asthma 109,610 1 0.00 -0.97 0.05 0.57
Kallikrein-8 19 Target Disease Inflammation 252,734 2 0.00 -0.95 0.11 0.57
AMAC-1 19 Target Disease Arthritis 128,324 1 0.00 -0.97 0.05 0.57
Complement Decay-Accelerating Factor 19 Target Target Collagen 138,882 1 0.00 -0.97 0.05 0.57
ALK Phos 19 Target Target Collagen 138,882 1 0.00 -0.97 0.05 0.57
Eotaxin-2/CCL24 19 Target Target Collagen 138,882 1 0.00 -0.97 0.05 0.57
Kallikrein-8 19 Target Target Collagen 138,882 1 0.00 -0.97 0.05 0.57
Aralen (Chloroquine)- FDA 19 Drug Disease Stroke 146,992 1 0.00 -0.97 0.05 0.57
Complement Decay-Accelerating Factor 19 Target Disease Leukemia 162,805 1 0.00 -0.97 0.05 0.56
464.1 19 Target Disease Leukemia 162,805 1 0.00 -0.97 0.05 0.56
Kallikrein-8 19 Target Disease Leukemia 162,805 1 0.00 -0.97 0.05 0.56
ALK Phos 19 Target Disease Hepatitis 163,842 1 0.00 -0.97 0.05 0.56
AMAC-1 19 Target Disease Breast Cancer 173,695 1 0.00 -0.97 0.05 0.56
Aralen (Chloroquine)- FDA 19 Drug Disease Breast Cancer 173,695 1 0.00 -0.97 0.05 0.56
ALK Phos 19 Target Disease Breast Cancer 173,695 1 0.00 -0.97 0.05 0.56
464.1 19 Target Disease Cholesterol 182,390 1 0.00 -0.97 0.05 0.56
Complement Decay-Accelerating Factor 19 Target Disease Inflammation 252,734 1 0.00 -0.97 0.05 0.55
464.1 19 Target Disease Inflammation 252,734 1 0.00 -0.97 0.05 0.55
ALK Phos 19 Target Disease Inflammation 252,734 1 0.00 -0.97 0.05 0.55
Tegument Protein Vp16 19 Target Disease Inflammation 252,734 1 0.00 -0.97 0.05 0.55
Aralen (Chloroquine)- FDA 19 Drug Disease Infection 766,637 2 0.00 -0.95 0.11 0.55
Aralen (Chloroquine)- FDA 19 Drug Disease Pain 409,851 1 0.00 -0.97 0.05 0.54
Mu-Type Opioid Receptor 19 Target Disease Pain 409,851 1 0.00 -0.97 0.05 0.54
ALK Phos 19 Target Disease Pain 409,851 1 0.00 -0.97 0.05 0.54
Tegument Protein Vp16 19 Target Disease Pain 409,851 1 0.00 -0.97 0.05 0.54
Complement Decay-Accelerating Factor 19 Target Disease Cancer 1,053,491 2 0.00 -0.95 0.11 0.54
Complement Decay-Accelerating Factor 19 Target Disease Infection 766,637 1 0.00 -0.97 0.05 0.53